Introduction
The murine skull vault consists of mainly two different skeletal elements, the frontal and parietal bones. Each component is formed from entirely different tissue origins during development, cranial neural crest (CNC) or cephalic mesoderm, respectively (Jiang et al., 2002) . Previous studies using transgenic mouse models have demonstrated that CNC contributes to the formation of the frontal bone but not the parietal bone during embryonic development (Jiang et al., 2002; Tyler, 1983) . The parietal bone is derived from cephalic mesoderm and both the frontal and parietal bone are formed by intramembranous bone formation. Despite the fact that the parietal bone occupies a large portion of the skull vault, most studies have been focused on the mechanism of CNC derived craniofacial bone development (Han et al., 2007; Ishii et al., 2003; Sasaki et al., 2006) . In this study, we address the cell autonomous roles of Tgfbr2 in development of the skull vault.
Intramembranous bone formation is a series of events covering the commitment of mesenchymal cells to the osteoblast lineage, to maturation of osteoblast characterized by deposition of mineralized bone matrix. Each step for osteoblast differentiation is strictly regulated by several transcription factors (Franceschi et al., 2008; Karsenty and Wagner, 2002; Marie, 2008) . Runx2/Cbfa1 has been identified as one of the major transcription factors responsible for osteoblast differentiation. It is expressed as mesenchymal cells are committed to the osteoblast lineage and throughout the differentiation process. Runx2/Cbfa1 mutant mice showed arrested osteoblast differentiation in all developing skeletal elements (Komori et al., 1997) . Another key molecule, Osterix/Sp7, is a zinc finger transcription factor exclusively expressed in osteoblasts that acts downstream of Runx2/Cbfa1 during skeletal development (Celil et al., 2005; Nakashima et al., 2002) . In Osterix null mutant mice, endochondral and intramembranous bone formation were affected, but the failure of osteoblast differentiation occurred at a later step than in Runx2/Cbfa1 null mice. Several growth factors such as TGFβ1 and BMP2 are known to regulate expression of these transcription factors. TGFβ1 and BMP2 treatment promoted Runx2/Cbfa1 expression in osteoblast cell lines (Hay et al., 2004; Lee et al., 2000) and Tgfbr2 deletion in CNC derived frontal bone primodium resulted in a decrease in Runx2/Cbfa1 and Osterix/Sp7 expression (Sasaki et al., 2006) .
TGFβ is a member of the highly conserved TGFβ/BMP family of multi-functional peptides. Each member in this family is a structurally similar peptide that regulates multiple aspects of development such as cell growth, differentiation, proliferation, and formation of extracellular matrix (Dunker and Krieglstein, 2000; Ito et al., 2003; Kingsley, 1994; Mummery, 2001; Serra and Chang, 2003; Verrecchia and Mauviel, 2002) . TGFβ ligands initiate signaling pathways via binding to their receptor, TGFβRII, which is a constitutively active serine/threonine kinase. Binding of the ligands to TGFβRII triggers formation of a heterotetrameric complex consisting of two TGFβRII and two TGFβ type I receptors (TGFβRI). The formation of the complex enables TGFβRII to phosphorylate TGFβRI resulting in activation of TGFβRI. Activated TGFβRI phosphorylates downstream molecules, Smad2/3, which results in complex formation with Smad4. Consequently, the Smad complex translocates into nucleus and induces cellular responses as a result of Smad transcriptional regulatory activity.
Recent studies using transgenic mouse models demonstrated the significance of TGFβ signaling in the formation of skull. Mice with germline deletion of the ligand Tgfb2 showed mild defects in bone size and ossification in frontal, interparietal, parietal, and squamosal bones at E18.5 day (Sanford et al., 1997) . TGFβ2/3 double knockout mice demonstrated significantly reduced frontal and parietal bones at E15.5 day, suggesting that TGFβ ligands are functionally redundant in skull development (Dunker and Krieglstein, 2002) . Conditional inactivation of Tgfbr2 in Wnt1Cre expressing CNC cells revealed significant defects in development of the frontal bone as well as the parietal bone. Since Wnt1Cre is not expressed in the parietal bone, it was suggested that paracrine effect of TGFβ was at work in the developing skull. Wnt1Cre is active in the meninges underlying the developing skull and it was suggested that the interaction of the meninges with the parietal bone was critical for normal development (Ito et al., 2003; Sasaki et al., 2006) . This result led us to investigate the cell autonomous functions of TGFβ signaling in the developing skull. To examine the cell autonomous effects of Tgfbr2 in parietal bone development, we specifically deleted Tgfbr2 in mesenchymal cells within the presumptive parietal and frontal bones using Prx1Cre mediated recombination. Prx1Cre + /Tgfbr2 f/f mice were dead at birth showing severe defects in frontal and parietal bones. The first sign of skull defects in mutant embryos was detected at E14.5 day by H&E staining. The failure of frontal and parietal bone formation in mutant embryos was shown to be primarily the result of reduced mesenchymal proliferation. Marker analysis also showed alterations in expression of Runx2/Cbfa1 and Osterix/Sp7. Generally, normal development of the skeletal elements during embryogenesis requires a certain level of cell density as well as signals directing their differentiation. Missing either one can result in the failure of normal development. To determine whether the alterations in osteogenic marker expression in Prx1Cre + /Tgfbr2 f/f embryos were an independent effect of the loss of Tgfbr2 or whether a consequence of decreased osteoprogenitor cell proliferation, we examined the expression of osteoblast markers in Tgfbr2 f/f cells treated with Ad-Cre or Ad-EGFP virus in cultures under conditions of high cell density. The mRNA levels of Runx2/ Cbfa1 and Osterix/Sp7 were down-regulated in Ad-Cre-treated cultures compared to Ad-EGFP-treated control cells indicating that the requirement of Tgfbr2 for osteoblast differentiation is independent of proliferation and cell density. Together, our results suggest that Tgfbr2 is required for normal development of the skull and acts in a cell autonomous manner to regulate mesenchymal proliferation and osteoblast differentiation.
Materials and methods

Mouse crosses
Mice in which exon2 of Tgfbr2 was flanked with loxP sites (Tgfbr2 f/f ) were obtained from Dr. H.L Moses, Vanderbilt University, Nasshville, TN (Chytil et al., 2002) . Tgfbr2 f/f mice were crossed to transgenic mice that express Cre under the control of the Prx1 promoter (obtained from Dr. Clifford J. Tabin, Harvard Medical School, Boston, Massachusetts) (Logan et al., 2002) to create a mouse in which Tgfbr2 was deleted in calvarial osteoprogenitors. The genotype of adult transgenic mice and embryos was determined by PCR analysis as previously described (Baffi et al., 2004; Seo and Serra, 2007) .
Semi-quantitative RT-PCR analysis
RNA was isolated from calvarial osteoprogenitors from E14.5 day embryos and cultured cells using the standard Trizol method. mRNA concentration was measured by ND-1000 UV spectrophotometry (Nanodrop). For semi-quantitative RT-PCR analysis, cDNA was synthesized from 2.5 μg of total mRNA using random primers and 20-100 ng of cDNA template was amplified for 20, 25 and 30 or 25, 30 and 35 cycles. PCR was performed using the following primers: Runx2/Cbfa1 primers (forward 5′-TCA TGG CCG GGA ATG ATG AGA ACT-3′ and reverse 5′-AGC TTC TGT CTG TGC CTT CTT GGT-3′), Osterix/Sp7 (forward 5′-TCC CTT CTC AAG CAC CAA TGG ACT-3′, reverse 5′-AAG TGT AGA CAC TAG GCA GGC AGT-3′), Dlx5 primers (forward 5′-TAG GAC TGA CGC AAA CAC AGG TGA-3′ and reverse 5′-GAA TTG ATT GAG CTG GCT GCG CTT-3′), Msx2 primers (forward 5′-TTC TCC GAC TAA AGG CGG TGA CTT-3′ and reverse 5′-TCC GGT TGG TCT TGT GTT TCC TCA-3′), Tgfbr2 exon2 primers (forward 5′-TTA ACA GTG ATG TCA TGG CCA GCG-3′ and reverse 5′-AGA CTT CAT GCG GCT TCT CAC AGA-3′), 18S primers (forward 5′-ACG GGA GGG CAC CAC CAG G-3′, reverse 5′-CAC CAA CTA AGA ACG GCC ATG C-3′), Histone H4b primers (forward 5′-ACA ACA TCC AGG GCA TCA CCA A-3′, reverse 5′-TTG AGC GCG TAG ACC ACG TCC AT-3′). Fold difference in expression level was calculated based on band intensity using histogram in Photoshop software. Pixel densities of three sets of each gene were measured, and mean value was calculated and normalized with 18S. The efficiency of DNA amplification was determined by varying the number of cycles for each primer pair. Results are shown in the linear range of product formation.
Skeletal staining
To investigate the skeletal structure in developing skull vault, E15.5 and 18.5 day embryos were double-stained for bone and cartilage with Alizarin red and Alcian blue (Kimmel and Trammell, 1981; McLeod, 1980) . Staining was performed as previously described (Seo and Serra, 2007) . Images were captured using an Olympus SZ12 stereo-microscope and magnafire digital camera.
Histology
Female mice at E13.5, E14.5, E15.5, and E16.5 days gestation were dissected for embryos. Noon on the day of the vaginal plug is E0.5 day. Embryos were fixed in 4% paraformaldehyde at room temperature for 2 h, dehydrated in ethanol solution and embedded in paraffin. Sections were cut at a thickness of 5-6 μm and mounted on Superfrost Plus slides (Fisher). For histological analysis, sections were stained with hematoxylin and eosin (H&E). For Prx1Cre + /R26R reporter mice, embryos at E13.5 and 15.5 were fixed in 4% paraformaldehyde for 30 min at 4°C and permeabilized in permeabilization solution (2 mM MgCl 2 , 0.01% NaDeoxycholate, 0.02% NP-40 in PBS) for 10 min at room temperature twice. Following permeabilization, embryos were incubated in X-gal staining solution (2 mM MgCl 2 , 5 mM K ferncyanide, 5 mM K ferrocynaide, 1 mg/ml X-Gal in PBS) overnight at room temperature. After post-fixation, embryos were sectioned as described above. Sections were dewaxed and mounted. Images were captured with an Olympus BX-51 fluorescent microscope and macrofire digital camera.
von Kossa Staining
To examine mineralization, sections from E15.5 embryos were incubated in 1% silver nitrate for 30 min while under sun light. Unreacted silver was washed with 5% sodium thiosulfate and distilled water for 5 min each. Sections were dehydrated and coverslipped using permanent mounting medium.
Immunofluorescence staining
Prepared sections were incubated with rabbit anti-Osterix/Sp7 antibody (Abcam, diluted 1:200) as a primary antibody and goat biotinylated anti-rabbit IgG as a secondary antibody. Fluorescent signal was detected with Avidin-conjugated Cy3 and sections were counterstained with DAPI or Yopro. For Runx2/Cbfa1 staining, M.O.M kit (Vector) was used according to the manufacturer's instructions with mouse anti-Runx2 antibody (MBL, diluted 1:200) as a primary antibody. Slides were mounted with Aqua poly/Mount (Polyscience Inc.).
Cell proliferation and TUNEL labeling
Cell proliferation was measured by BrdU staining. 60 μg/g (BrdU/ body weight) of BrdU was injected intraperitoneally into the female mice at 13.5 and 14.5 days gestation 1 h before sacrifice and removal of embryos. Rat monoclonal anti-BrdU antibody (Abcam) was used as described above for immunofluorescence staining. For TUNEL staining, TdT-Frag EL™ Fragmentation Detection Kit (Calbiochem) was used according to the manufacturer's instructions.
Osteoblast culture
Calvarial tissue containing osteoprogenitors were dissected and separated from Tgfbr2 f/f embryos at E14.5 day. Separated tissue was dissociated into a single cell suspension with incubation with 1 mg/ml of collagenase D and 0.1% trypin EDTA in DPBS for 30 min at 37°C. 5 × 10 6 cells were plated to a 6 well plate and pre-incubated in growth medium for 3 days at 37°C in CO 2 incubator. After preincubation allowing cells to reach confluence, the cells were incubated with Adeno-Cre-EGFP virus to remove Tgfbr2 and with Adeno-EGFP virus as a control. After 24 h, cells were fed with differentiation medium (MEM containing 10 % FBS, 50 μg/ml ascorbic acid, 10 mM β-glycerolphosphate, 2 mM glutamine, antibiotics). Cells were incubated at 37°C in CO 2 incubator for another 3 days. Medium was replaced every 2 days. Following incubation, mRNA was isolated for further RT-PCR analysis as described above.
Results
Deletion of Tgfbr2 in the developing skull
The frontal and parietal bones are major components of the skull vault covering medial and lateral aspect of the brain. They are formed by intramembranous bone formation in which mesenchymal cells directly differentiate into osteoblasts. Previously, it was shown that loss of Tgfbr2 in the meninges, which is derived from CNC, results in defects in development of the parietal bone suggesting paracrine effects of TGFβ (Sanford et al., 1997; Sasaki et al., 2006) . To determine if TGFβ signaling is also required in a cell autonomous manner for normal development of the parietal bone, Tgfbr2 was deleted by Cre mediated recombination in the skull using Prx1Cre as previously described (Seo and Serra, 2007) . To determine the exact location of Prx1Cre recombinase activity in the developing skull, Prx1Cre + mice were crossed with R26R reporter mice, and embryos at E13.5 and 15.5 day were stained by X-gal and sectioned for further analysis (Figs. 1B-G) . Sagittal sections of E13.5 day Prx1Cre/R26R embryos showed strong X-gal staining in the mesenchymal cells covering the entire developing brain from anterior of the presumptive frontal bone to posterior of the presumptive parietal bone (Figs. 1B-D) . In E15.5 embryos, Cre recombinase activity was limited to the dermis and the osteoprogenitor layer in both presumptive frontal and parietal areas (Figs. 1E-G). Activity was not detected in the skin or the meninges, which are derived from ectoderm (Ito et al., 2003; Jiang et al., 2002) . Deletion of Tgfbr2 was confirmed by RT-PCR (Fig. 1A) embryos showed more details of the defects (Fig. 3) . The black and white lines in Fig. 3A show the location of the transverse sections revealing the lateral aspect of the skull (Figs. 3B-K), and the location of the sagittal sections revealing the medial aspect of the skull (Figs. 3L-O) . The thickness of the osteoprogenitor cell layer in mutant embryos was similar to control embryos at E13.5 days (Figs. 3B, C, brackets). However, the thickness of this layer in both presumptive frontal and parietal bones was slightly reduced at E14.5 day (not shown) and significantly reduced after E15.5 day in Prx1Cre + /Tgfbr2 f/f embryos relative to controls (Figs. 3D-G, lower brackets). In E15.5 day control embryos, we were able to see mineralization along the entire skull, but little to no mineralization was observed in Prx1Cre + /Tgfbr2 f/f embryos (Figs. 3H-K, arrowheads). Formation of the epidermis of the skin, and meninges in E15.5 day mutant embryos were similar to control embryos but the size of the dermis layer was also significantly reduced in the mutant embryos (Figs. 3D-G upper brackets). Midsagittal sections of E16.5 day Prx1Cre + /Tgfbr2 f/f embryos showed more significant reduction in the size of frontal and parietal bones compared to control embryos (Figs. 3L-O) and there was no detectable mineralization (not shown). The reduction in size and cell density of the mesenchymal layers suggested that cell proliferation could be responsible for the failure of the formation of the skull vault in Prx1Cre − /Tgfbr2 f/f embryos.
Loss of Tgfbr2 results in a decrease in cell proliferation but does not alter cell survival in the developing parietal bone
To examine the mechanism responsible for the failure of skull development, we compared the level of cell proliferation and apoptosis in the presumptive parietal bone from Prx1Cre + /Tgfbr2 f/f and Cre − control embryos at E13.5 and E14.5 days. Cell proliferation was measured as the percentage of cells that incorporated BrdU. Since bone formation in the skull vault occurs from the lateral aspect to the dorsal aspect of the skull, we examined proliferation at both sides of the skull using transverse sections (Figs. 4A, C, D, F) of E13.5 and E14.5 day embryos, and the top of the skull using midsagittal sections (Figs. 4B, E) of E13.5 day embryos. At E13.5 day, the percentage of BrdU positive cells in the lateral aspects of E13.5 day Prx1Cre + /Tgfbr2 f/f skull was reduced when compared with control embryos, but it was not determined to be statistically significant (Figs. 3A, D, G) . However, a significant reduction in the percentage of proliferating cells was detected in the medial aspects of the parietal bone at this stage (Figs. 3B, E, H). At E14.5 day, there was significantly reduced cell proliferation within the lateral aspect of the parietal bone in the Prx1Cre + /Tgfbr2 f/f embryos (Figs. 3C, F,   I ). The same pattern of cell proliferation was detected in the presumptive frontal bone of mutant and control embryos at E13.5 and E14.5 days (data not shown). This result suggests that reduced cell proliferation in skull mesenchyme is one of the factors responsible for the failure of skull bone development in Prx1Cre + /Tgfbr2 f/f embryos.
To determine whether alterations in apoptosis contributed to the disruption of skull development, we measured apoptosis in cells of the developing parietal bone in Prx1Cre + /Tgfbr2 f/f and control embryos at E13.5 and E14.5 day using TUNEL analysis. TUNEL-stained cells were not detected in either Cre − controls or 
Deletion of Tgfbr2 results in reduced expression of osteoblast markers
To test whether the defects in skull bone development were also due to alterations in osteoblast differentiation, we examined the expression of Runx2/Cbfa1 and Osterix/Sp7 in Prx1Cre + /Tgfbr2 f/f and control embryos at E13.5, E14.5 and E15.5 days (Fig. 5) . Runx2/ Cbfa1 is a key transcription factor for osteoblast differentiation (Komori et al., 1997; Otto et al., 1997) . Normal Runx2 expression was detected in lateral aspects of E13.5 and E14.5 day control embryos, and in the medial roof of E15.5 day control embryos (Figs. 5A, C, E). E13.5 day Prx1Cre + /Tgfbr2 f/f embryos showed a similar expression pattern with control embryos (Fig. 5B) . However, starting from E14.5 day, Runx2/Cbfa1 expression was not detected in either lateral or medial aspect of the developing parietal bone (Figs. 5D, F) . It has been shown that Osterix/Sp7 acts downstream of Runx2/Cbfa1 and upregulates expression of osteoblast marker genes (Celil et al., 2005; Fu et al., 2007; Nakashima et al., 2002) . The expression of Osterix/Sp7 showed the same expression pattern of Runx2/Cbfa1 (Figs. 5G-L). Osterix/Sp7 expression was comparable in control and mutant embryos at E13.5, but it was not detected in E14.5 and E15.5 day mutant embryos compared to control embryos. This result suggests that loss of Tgfbr2 also affects differentiation of osteoblasts. However, it is not clear if this is a direct effect on differentiation or a consequence of reduced cellular proliferation.
Tgfbr2 is required for osteoblast differentiation independent of effects on cell proliferation
Mesenchymal condensation is known to be required for the initiation of intramembranous bone formation during skeletal development. Low cell density leads to the failure of cell condensation, which can consequently result in defects in skeletal development, suggesting that a certain level of cell density is required for the initiation of differentiation. Since we showed a decrease in proliferation of the mesenchyme in the presumptive skull bones of Prx1Cre 
Tgfbr2
f/f embryos, we decided to determine whether altered expression of osteoblast markers is due to the loss of Tgfbr2 directly or if it is a consequence of reduced cell proliferation and reduced cell density. To this end, we examined expression of osteoblast markers in cells with deletion of Tgfbr2 cultured under conditions of high cell density. To accomplish both the deletion of Tgfbr2 and high cell density, skull mesenchyme from E14.5 day Tgfbr2 f/f embryos was plated at 70% density and allowed to grow for 3 days to reach confluence before deletion of Tgfbr2. At confluence, Ad-Cre or Ad-EGFP virus, as a control, was added to the cultures to remove Tgfbr2. Three days after virus treatment, mRNA was isolated for RT-PCR analysis (Fig. 6 ). There were no alterations in the morphology of the cells over the time course of the experiment (Fig. 6A) . Ad-Cre-infected cells showed significant loss of Tgfbr2 mRNA (Fig. 6B) . In Ad-Creinfected cultures, mRNA levels of Runx2/Cbfa1 and Osterix/Sp7 were significantly decreased even under the condition of high cell density when compared to Ad-EGFP-infected or uninfected controls (Fig. 6C) . Furthermore, Dlx5 and Msx2 expression were significantly downregulated in Ad-Cre-infected culture compared to Ad-EGFP-infected and uninfected control cells (Fig. 6C ). Dlx5 is known as an essential transcription factor for the differentiation of calvarial osteoblasts. Dlx5 mutant mice demonstrated delayed skull ossification (Acampora et al., 1999; Robledo et al., 2002) . Moreover, over-expression of Dlx5 induced Runx2/Cbfa1 expression in chick mesenchyme in vitro (Holleville et al., 2007) . It was also shown that Msx2 is expressed in the developing parietal bone and Msx1/2 double knockout mice display severe defects in skull formation (Han et al., 2007; Ishii et al., 2003; Satokata et al., 2000) . Histone H4b primers were used to test for differences in cell proliferation (Holmes et al. 2005) . Expression of histone H4b in Ad-Cre-infected cells was comparable to both Ad-EGFP-infected and uninfected control cells (Fig. 6C) suggesting proliferation was not affected by deletion of Tgfbr2 in the confluent cultures. Similar results were seen in three separate experiments. Together, these results suggest that alterations in proliferation and differentiation in Tgfbr2-deleted mesenchyme are independent effects.
Discussion
The vertebrate skeleton is produced from three embryonic lineages. The appendicular skeleton is formed by lateral plate mesoderm, the axial skeleton is derived from paraxial mesoderm, and craniofacial bones are derived from cephalic mesoderm and cranial neural crest, which originates from ectoderm (Olsen et al., 2000) . During skeletal development, cells in these lineages migrate to their target location, condense, and begin the differentiation processes to form skeletal elements. There are two mechanisms for skeletal development: endochondral bone formation and intramembranous bone formation. These two processes can be distinguished by the cartilage model that is formed during endochondral bone formation. In contrast to endochondral bone formation, intramembranous bone formation is a relatively simple mechanism. Mesenchymal cells condense and directly differentiate into osteoblasts. Most studies of intramembranous bone formation have focused on cranial neural crest lineages (Iseki et al., 1999; Ishii et al., 2005 Ishii et al., , 2003 Ito et al., 2003; Sasaki et al., 2006; Tyler, 1983) . Previous cell tracing studies using Wnt1Cre/R26R showed that cranial neural crest contributes to the frontal bone but not the parietal bone (Chai et al., 2000) . The meninges lying underneath both the frontal and parietal bones is also derived from cranial neural crest. Mice with conditional inactivation of Tgfbr2 using Wnt1Cre demonstrated severe defects in the parietal bone as well as the frontal bone even though Wnt1Cre is not expressed in precursors of the parietal bone. It was suggested that TGF-β signaling in the meninges was required for proper skull development (Ito et al., 2003; Sasaki et al., 2006) . To examine the cell autonomous effects of Tgfbr2 on development of the skull bones, we used Prx1Cre to delete Tgfbr2 in the developing skull mesenchyme. Mice carrying Prx1Cre recombinase were crossed to mice in which exon 2 of Tgfbr2 was flanked with loxP sites, resulting in conditional deletion of Tgfbr2 primarily in limb mesenchyme and in the skull mesenchyme (Logan et al., 2002) . By E15.5 days, Prx1Cre activity was specifically detected in the dermis and in the osteoprogenitor cell layer of the skull, but it was not detected in epidermis or meninges. Skeletal staining of E15.5 and E18.5 day embryos displayed severe defects in the skull vault including a failure in the formation of both the frontal and parietal bones. The results suggest that in addition to the signals from the meninges, Tgfbr2 can also act in a cell autonomous manner to regulate development of the skull bones. Mice with a germline deletion of the TGFβ2 ligand as well as TGFβ2/3 double knockout mice presented with defective frontal and parietal bone development, which is consistent with our results (Dunker and Krieglstein, 2002; Sanford et al., 1997) . On the other hand, in the Prx1Cre
f/f mice, the interparietal bone was only slightly reduced just in the intramembranous portion but the chondrogenic portion was not severely affected. Our previous study showed normal initiation of chondrocyte differentiation in the limb buds of Prx1Cre + /Tgfbr2 f/f embryos (Seo and Serra, 2007) . Mesenchymal condensation and the commitment to chondrocyte differentiation in the limbs of E12.5 day Prx1Cre + /Tgfbr2 f/f embryos were normal. Likewise, loss of Tgfbr2 in the sclerotome did not affect chondrocyte differentiation or expression of Sox9 (Baffi et al., 2004 , Baffi et al., 2006 . These results again suggest that Tgfbr2 is not required for the initiation of chondrogenesis, at least at the stages under study. In H&E staining of E14.5 and E15.5 day mutant and control embryos, the size of the osteoprogenitor cell layer in Prx1Cre + / Tgfbr2 f/f embryos was reduced suggesting that cell proliferation was decreased. As we expected, BrdU labeling assays demonstrated significantly decreased proliferation of cells in the presumptive frontal and parietal bones of E13.5 mutant embryos, even though there were regional differences in statistical significance. Previous studies using transgenic mice in which Tgfbr2 was removed from various skeletal elements showed a significant reduction in the proliferation of chondrocytes, osteoprogenitor cells, and palatal mesenchyme suggesting a primary function of Tgfbr2 in skeletal development is in regulating mesenchymal cell proliferation (Ito et al., 2003; Sasaki et al., 2006; Seo and Serra, 2007) . Intramembranous bone formation also takes place in the bone collar of the long bones, which is formed by cells in the periosteum surrounding the hypertrophic zone. The periosteum also displayed a significant reduction in size in Prx1Cre + /Tgfbr2 f/f embryos suggesting that Tgfbr2 may also be required for normal cell proliferation during formation of the bone collar (Seo and Serra, 2007) . It is likely that reduced thickness in the dermis was also due to decreased mesenchymal cell proliferation and that regulation of mesenchymal proliferation is a common biological effect of TGF-β signaling in many tissues. In addition to proliferation, E15.5 day mutant embryos showed a significant reduction in mineralization in the developing skull indicating osteoblast differentiation was also affected in Prx1Cre + / Tgfbr2 f/f embryos. Marker analysis using immunofluorescence staining to examine osteoblast differentiation in mutant and control embryos revealed that the level of Runx2/Cbfa1 and Osterix/Sp7 protein, which are early markers of osteoblast differentiation, were significantly down-regulated in the mutant embryos by E14.5 day indicating that osteoblast differentiation was altered. Whether this was a direct effect of TGF-β on differentiation or a consequence of reduced cell proliferation was not immediately clear. Intramembranous bone formation starts with the condensation of mesenchymal cells (Hall and Miyake, 2000) . This condensed population of cells grows and once they reach a critical level of cell density, cells at the center of the condensation begin differentiation into osteoblast. That is, without enough cell density, osteoblast differentiation can fail. However, most previous studies using transgenic mouse models to consider the role of TGF-β in skeletal development concluded that loss of Tgbr2 is directly responsible for alterations in osteoblast marker expressions without considering reduced cell density. To show that decreased marker expressions in Prx1Cre + /Tgfbr2 f/f embryos was not simply a consequence of a failure of the mesenchyme to reach a critical density, we tested for the expression of osteoblast markers in primary osteoprogenitor cells grown in high-density culture in the presence or absence of Tgfbr2. In culture, Tgfbr2 was removed using Ad-Cre after the cells had reached confluence. As a result, both Runx2/Cbfa1 and Osterix/Sp7 expressions in Ad-Cre virus-infected cells was downregulated when compared to Ad-EGFP-infected and uninfected control cells. Histone H4b, a marker of cell proliferation (Holmes et al., 2005) , was not altered by loss of Tgfbr2 in the confluent cultures. This result suggests that Tgfbr2 regulates osteoblast differentiation and proliferation independently. In summary, the results presented here provide information regarding signaling though Tgfbr2 and the mechanisms of intramembranous bone formation in mouse skull. 
